(IN BRIEF) Antibiotice SA, a leading Romanian manufacturer of generic drugs, has signed a new advisory agreement with the European Investment Bank (EIB) to help build its capacity to develop new generic drugs, improve production processes, and strengthen its local … Read the full press release
Posted in Banks, Business, European Union, Financial, Investment, Pharma & Biotech, Romania
Tagged Antibiotice SA, EIB, generic drugs, Hristo Stoykov, Ioan Nani, Romanian company
(IN KÜRZE) Die LEGO Group und Novo Nordisk haben sich mit European Energy zusammengetan, um E-Methanol, eine kohlenstoffärmere Alternative zu herkömmlichem Kunststoff, für einen Teil ihrer Materialproduktion zu verwenden. European Energy wird E-Methanol aus erneuerbarer Energie und biogenem CO2 produzieren, … Read the full press release
(IN BRIEF) The LEGO Group and Novo Nordisk have partnered with European Energy to use e-methanol, a lower-carbon alternative to conventional plastic, for some of their material production. European Energy will produce e-methanol from renewable energy and biogenic CO2, and … Read the full press release
(IN KÜRZE) Das BioSense Institute in Novi Sad hat ein neues Gebäude eröffnet, das moderne Einrichtungen für wissenschaftliche Forschung und Geschäftsvorhaben in den Bereichen Landwirtschaft und Biotechnologie bietet. Das 34-Millionen-Euro-Projekt wurde mit 14 Millionen Euro an EU-Zuschüssen, 20 Millionen Euro … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged Ana Brnabić, ANTARES-Projekt, BioSense Institute, biotechnologie, Biowissenschaften, Branko Ružić, EIB, Europäische Investitionsbank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, Jugend Mariya Gabriel, Landwirtschaft, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, Serbien, start-ups, Tanja Miščević, Universität Novi Sad, Vladimir Crnojević, wissenschaftliche Forschung
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged agriculture, Ana Brnabić, ANTARES project, BioSense Institute, biotechnology, Branko Ružić, EIB, European Investment Bank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, life sciences, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, scientific research, SERBIA, Startups, Tanja Miščević, University of Novi Sad, Vladimir Crnojević, Youth Mariya Gabriel
(NOTICIA EN BREVE) Sanofi ha nombrado a Elisabeth Moreno, exministra francesa de Igualdad de Género, Diversidad e Igualdad de Oportunidades, para su Junta de Diversidad, Equidad e Inclusión (DE&I) para los próximos tres años. El consejo asesor se creó en … Read the full press release
Posted in Business, France, Management, Pharma & Biotech
Tagged Caroline Casey, Dell, derechos humanos, diversidad, Dr. Rohini Anand, Elisabeth Moreno, Emmanuel Macron, France Télécom, Hewlett Packard, igualdad de género, Igualdad de oportunidades, Junta DE&I, Lenovo, lucha contra la discriminación, nombramiento, Paul Hudson, Sanofi
(IN BRIEF) Sanofi has appointed Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal Opportunities, to its Diversity, Equity and Inclusion (DE&I) Board for the next three years. The advisory council was created in 2022 to support Sanofi’s … Read the full press release
Posted in Business, France, Management, Pharma & Biotech
Tagged appointment, Caroline Casey, DE&I Board, Dell, diversity, Dr. Rohini Anand, Elisabeth Moreno, Emmanuel Macron, Equal opportunities, fight discrimination, France Télécom, gender equality, Hewlett Packard, human rights, Lenovo, Paul Hudson, Sanofi
(IN BRIEF) AstraZeneca is set to present data on its Vaccines and Immune Therapies portfolio at the European Congress of Clinical Microbiology & Infectious Diseases. Among the data to be presented will be details on the progress of AstraZeneca’s Vaccines … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, AZD3152, Beyfortus, ECCMID 2023, Evusheld, Immune Therapies, Iskra Reic, vaccines, Vaxzevria
(IN BRIEF) AstraZeneca will showcase new data from its industry-leading Oncology pipeline and portfolio at the American Association for Cancer Research Annual Meeting. A total of 70 presentations will be given, including a plenary presentation on the AEGEAN Phase III … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, AZD5335, AZD9592, early-stage, Imfinzi, lung cancer, oncology, Susan Galbraith, treatment
(IN BRIEF) Evonik, the global specialty chemicals company, has won the Best New Bioprocessing Supplier in Upstream Processing award for its innovative Cell Culture Solutions portfolio at the Asia-Pacific Bioprocessing Excellence Awards (ABEA). The awards celebrate exceptional organizations and technologies … Read the full press release
(IN BRIEF) The Food and Drugs Authority of Ghana has granted full national licensure for the R21/Matrix-M malaria vaccine developed by the University of Oxford and manufactured by the Serum Institute of India using Novavax’s adjuvant technology. This marks the … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged Adar Poonawalla, CHILDREN, Dr Kofi Nsiah-Poku, FDA Ghana, GHANA, John C. Jacobs, malaria vaccine, Novavax, Oxford, Prof. Adrian Hill, R21/Matrix-M malaria vaccine, Serum Institute of India, University of Oxford
(NOTIZIA IN BREVE) La Banca europea per gli investimenti (BEI) ha investito 15 milioni di euro in Neuromod Devices Ltd per supportare la commercializzazione del suo dispositivo per il trattamento dell’acufene, Lenire. Il dispositivo ha ottenuto l’approvazione De Novo dalla … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Ireland, Pharma & Biotech
Tagged Alessio Beverina, bimodal neuromodulation device, De Novo, dispositivo di neuromodulazione bimodale, dispositivo medico, dispositivo per il trattamento dell'acufene, Dr. Manus Rogan, Dr. Ross O’Neill, European Investment Bank, FDA, Fountain Healthcare Partners, Lenire, medical device, Neuromod Devices Ltd, neuromodulation, neuromodulazione, Panakès Partners, Scientific Reports, TENT-A1, TENT-A2, Thomas Östros, tinnitus, tinnitus treatment device
(IN BRIEF) The European Investment Bank (EIB) has invested €15 million in Neuromod Devices Ltd to support the commercialization of its tinnitus treatment device, Lenire. The device has been granted De Novo approval from the US FDA and has shown … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Ireland, Pharma & Biotech
Tagged Alessio Beverina, bimodal neuromodulation device, De Novo, Dr. Manus Rogan, Dr. Ross O’Neill, European Investment Bank, FDA, Fountain Healthcare Partners, Lenire, medical device, Neuromod Devices Ltd, neuromodulation, Panakès Partners, Scientific Reports, TENT-A1, TENT-A2, Thomas Östros, tinnitus, tinnitus treatment device
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(ACTUALITÉ EN BREF) Novo Nordisk a annoncé une collaboration avec Aspect Biosystems pour développer des thérapies tissulaires bio-imprimées pour le traitement du diabète et de l’obésité. La collaboration tirera parti de la technologie de bioimpression d’Aspect et de l’expertise de … Read the full press release
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release
(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab) in the United States. Under the new arrangements, Sanofi will have full commercial control of nirsevimab in the U.S. Sanofi … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech
Tagged AstraZeneca, Beyfortus, commercialization, contractual agreements, nirsevimab, partnership, Sanofi, Sobi, USA
(IN BRIEF) Researchers have used neutrons from the Research Neutron Source Heinz Maier-Leibnitz to explore the structure of biomolecules, specifically a promising vaccine against multidrug resistant bacteria. The vaccine consists of biomolecules with sizes in the order of 100 nanometers, … Read the full press release
Posted in Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged analysis, bacteria, biomolecules, Dr. Marco Maccarini, neutron, vaccine development
(IN BRIEF) A team led by Dr. Christoph F. Kurat from LMU’s Biomedical Center has discovered that a regular nucleosome structure is crucial for DNA replication to occur at certain points in the genome. Contrary to the textbook view that … Read the full press release
Posted in Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged cell nucleus, chromatin, DNA, Dr. Christoph F. Kurat, Erika Chacin, histones, LMU, nucleosomes, protein complex ORC, replication
(ACTUALITÉ EN BREF) Nordic Investment Bank (NIB) et Elekta AB, un fabricant suédois d’équipements médicaux, ont conclu un accord de prêt de 50 millions d’euros sur 7 ans pour financer des investissements de R&D dans des solutions et des traitements … Read the full press release
Posted in Banks, Financial, Finland, Healthcare, Investment, Pharma & Biotech, Sweden, Technology
Tagged André Küüsvek, apprentissage automatique, brachythérapie, Elekta AB, fabricant de matériel médical, financement, intelligence artificielle, Maurits Wolleswinkel, NIB, Pret, radiochirurgie, radiothérapie, soins avancés contre le cancer, solutions oncologiques, traitement oncologique
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?